For example, PRDM9 exhibits a significant mean up regulation in the ovarian cancer microarray sets used (Fig. 4); however, it is not significantly up regulated in all the individual cancer samples tested, despite the significant mean elevation (Fig. 5). Here, PRDM9 is linked to ovarian carcinoma.